Invention Grant
- Patent Title: Method of treatment based on ATAD2 inhibitors
- Patent Title (中): 基于ATAD2抑制剂的治疗方法
-
Application No.: US13879635Application Date: 2011-10-25
-
Publication No.: US08691747B2Publication Date: 2014-04-08
- Inventor: Laurens Kruidenier , Kevin Lee , David Francis Tough , David Matthew Wilson
- Applicant: Laurens Kruidenier , Kevin Lee , David Francis Tough , David Matthew Wilson
- Applicant Address: GB Brentford, Middlesex
- Assignee: Glaxo Group Limited
- Current Assignee: Glaxo Group Limited
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert H. Brink
- Priority: GB1018147.7 20101027
- International Application: PCT/EP2011/068675 WO 20111025
- International Announcement: WO2012/055880 WO 20120503
- Main IPC: A61K31/00
- IPC: A61K31/00
Abstract:
A method of treating autoimmune and inflammatory diseases or conditions in a mammal, such as a human, which comprises the administration of a inhibitor of the bromodomain-containing protein: ATAD2.
Public/Granted literature
- US20130224204A1 Method of Treatment Based on ATAD2 Inhibitors Public/Granted day:2013-08-29
Information query
